摘要
目的探讨恶性肿瘤患者血小板增多与病情及预后判断的关系。方法采用回顾性调查方法,以同期100例健康体检者为对照,分析117例恶性肿瘤患者血小板增多与肿瘤转移的关系。结果恶性肿瘤组血小板计数较正常对照组高,差异具有统计学意义(P<0.01)。临床分期Ⅲ～Ⅳ期患者血小板增多病例较临床分期Ⅰ～Ⅱ期的高,并且差异具有统计学意义(P<0.01)。结论恶性肿瘤患者血小板增多提示血小板与肿瘤的生长、转移有关。血小板增多可作为恶性肿瘤预后判断的参考指标。
Objective To investigate the clinical significance of thrombocytosis in patients with malig- nant tumors. Methods A total of 117 patients with malignant tumors were retrospectively investigated （the study group）, and 100 healthy subjects were observed as normal control （the control group）. The relationship between thrombocytosis and minor metastasis was analyzed. Results There was significant difference in thrombocyte count between the study group and 100 the control group （P〈0.01）. Thrombocytosis was positively correlated with clinical stage （P〈0.01）, with the incidence significantly higher in patients with clinical stage III-IVthan that with I - lI. Conclusion Thrombocytosis is associated with tumor growth and metastasis, which can serve as a use- ful marker to predict outcome of patients with malignant tumors.
出处
《海南医学》
CAS
2013年第14期2100-2102,共3页
Hainan Medical Journal
基金
海南省自然科学基金资助项目(编号:310132)
关键词
恶性肿瘤
血小板增多症
转移
预后
Malignant tumor
Thtombocytosis
Metastasis
Prognosis
